Adipose mesenchymal stem cell-based therapy: Anticancer molecular mechanisms in hepatoma model and bone marrow
Atia, M., Sallam, E., Aly, H., Alghriany, A. (2022). Adipose mesenchymal stem cell-based therapy: Anticancer molecular mechanisms in hepatoma model and bone marrow. EKB Journal Management System, 6(4), 31-49. doi: 10.21608/jcbr.2022.163847.1278
Mona M. Atia; Ebtehal T. Sallam; Hanem S. Aly; Alshaimaa A. I. Alghriany. "Adipose mesenchymal stem cell-based therapy: Anticancer molecular mechanisms in hepatoma model and bone marrow". EKB Journal Management System, 6, 4, 2022, 31-49. doi: 10.21608/jcbr.2022.163847.1278
Atia, M., Sallam, E., Aly, H., Alghriany, A. (2022). 'Adipose mesenchymal stem cell-based therapy: Anticancer molecular mechanisms in hepatoma model and bone marrow', EKB Journal Management System, 6(4), pp. 31-49. doi: 10.21608/jcbr.2022.163847.1278
Atia, M., Sallam, E., Aly, H., Alghriany, A. Adipose mesenchymal stem cell-based therapy: Anticancer molecular mechanisms in hepatoma model and bone marrow. EKB Journal Management System, 2022; 6(4): 31-49. doi: 10.21608/jcbr.2022.163847.1278

Adipose mesenchymal stem cell-based therapy: Anticancer molecular mechanisms in hepatoma model and bone marrow

Egyptian Journal of Cancer and Biomedical Research
Volume 6, Issue 4, December 2022, Page 31-49  XML PDF (18.43 MB)
Document Type: Original Article
DOI: 10.21608/jcbr.2022.163847.1278
View on SCiNiTO View on SCiNiTO
Authors
Mona M. Atia email orcid 1; Ebtehal T. Sallam1, 2; Hanem S. Aly1; Alshaimaa A. I. Alghriany3
1Department of Zoology and Entomology, Faculty of Science, Assiut University, 71516, Egypt
2Department of Biology, Faculty of Education, Taiz University, Yemen.
3Department of Zoology and Entomology , Faculty of Science, Assiut University, 71516, Egypt
Abstract
ABSTRACT

Background: Adipose-derived mesenchymal stem cells (AD-MSCs) can be used as therapeutic agents for the treatment of patients with HCC Aim: The study aimed to establish an animal model for hepatocellular carcinoma (HCC) by using diethyl nitrosamine (DEN) and carbon tetrachloride (CCl4) in a short time. Materials and Methods: Forty-five female rats were subdivided into three groups: control (G1), HCC model (G2), and therapeutic (G3). Each rat in the G2 groups was injected with DEN and after 1 week was injected again with CCl4, whereas G3 rats were injected with AD-MSCs immediately after the tumor appeared. Results: The injection of DEN/CCl4 was correlated with the increase in alanine transaminase, aspartate aminotransferase, and alpha-fetoprotein levels. Also, it caused oxidative stress as indicated by an increase in nuclear factor-erythroid factor 2-related factor-2 (Nrf2), vascular endothelial growth factor levels, and fibrosis. However, BCL2-associated X protein (BAX) was decreased. Transplantation of AD-MSCs induced apoptosis by increasing BAX and decreasing Nrf2 levels, which significantly inhibited angiogenesis. Histologically, our results indicated that AD-MSCs alleviated hepatocellular carcinoma, fibrosis, and nuclear morphology. Additionally, the bone marrow (BM) maturation index ratio parameter was restored to a normal stage. Conclusion: AD-MSCs have a wide range of targeted anticarcinogenic properties and can regenerate BM precursors of cellularity.
Keywords
Anticancer; AD-MSCs; HCC model; BM maturation index ratio
Statistics
Article View: 195
PDF Download: 213